ERMYCIN

This brand name is authorized in Cyprus, Malta, Singapore.

Active ingredients

The drug ERMYCIN contains one active pharmaceutical ingredient (API):

1	Erythromycin UNII 63937KV33D - ERYTHROMYCIN
	Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.
	Read more about Erythromycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ERMYCIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA01	Erythromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	AA084/07102
SG	Health Sciences Authority	07545P